Calamos Advisors LLC Reduces Stake in MetLife, Inc. (NYSE:MET)

Calamos Advisors LLC lowered its holdings in MetLife, Inc. (NYSE:MET) by 1.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 160,712 shares of the financial services provider’s stock after selling 2,100 shares during the quarter. Calamos Advisors LLC’s holdings in MetLife were worth $10,628,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of MET. FWL Investment Management LLC purchased a new stake in MetLife in the 4th quarter worth approximately $26,000. Quintet Private Bank Europe S.A. purchased a new position in shares of MetLife in the 3rd quarter valued at approximately $28,000. Planned Solutions Inc. purchased a new position in shares of MetLife in the 4th quarter valued at approximately $28,000. Eagle Bay Advisors LLC purchased a new position in shares of MetLife in the 2nd quarter valued at approximately $28,000. Finally, Studio Investment Management LLC purchased a new position in shares of MetLife in the 4th quarter valued at approximately $29,000. Hedge funds and other institutional investors own 89.81% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on MET. Piper Sandler raised their target price on MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. UBS Group lowered their target price on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a research note on Monday, February 5th. Keefe, Bruyette & Woods raised their target price on MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. Wells Fargo & Company raised their target price on MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Finally, Morgan Stanley lifted their price objective on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Monday, April 15th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $79.23.

MetLife Stock Up 1.7 %

MET stock opened at $71.11 on Friday. MetLife, Inc. has a 1-year low of $48.95 and a 1-year high of $74.68. The business has a fifty day moving average price of $71.12 and a 200-day moving average price of $66.77. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market capitalization of $51.41 billion, a P/E ratio of 38.86, a P/E/G ratio of 0.53 and a beta of 1.04.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The business had revenue of $18.72 billion during the quarter, compared to analysts’ expectations of $18.07 billion. Equities analysts forecast that MetLife, Inc. will post 8.71 earnings per share for the current fiscal year.

Insider Buying and Selling at MetLife

In other MetLife news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the sale, the insider now owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the sale, the insider now owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by corporate insiders.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.